3,4-Dihydropyrimidin-2(1H)-One Hybrids as Phenotypic Anti-Breast Cancer Agents: Synthesis, Colony-Formation Profiling and Computational Target Deconvolution
International Journal of Molecular Sciences · 27.10.2026 · 27 (21) · 9618
DOI: 10.3390/ijms27219618 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.10.2026. Verfasst von Hadeel D Sultan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Al-Balqa Applied University, P.O. Box 206, Al-Salt 19117, Jordan. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Pyrimidinones. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
3,4-Dihydropyrimidin-2(1H)-ones (DHPMs) are privileged heterocyclic scaffolds with broad biological activities. Sixteen DHPM hybrids (4a–p) carrying para- or ortho-aryloxy linkers and diverse terminal amines were prepared through a modular propargylation, Mannich-type, and Biginelli sequence. The compounds were ranked by NIH/3T3 cytotoxicity, MCF-7 antiproliferative activity (SRB assay), and colony formation under continuous exposure at the MCF-7 IC25. Compounds 4a and 4m were the most potent in MCF-7 cells (IC50 = 10.7 and 11.6 µM; preliminary selectivity indices of 9.6 and 9.1), but 4m inhibited colony formation by 68.3% compared with 25.3% for 4a, supporting its prioritization as the most balanced lead. Ligand-based target prediction followed by GNINA screening of seven candidate targets identified TOP2A as the best match to the experimental pIC50 ranking (Pearson r = 0.883, Spearman ρ = 0.893, n = 7), with Eg5/KIF11 as a secondary comparator. Docking, 200 ns molecular dynamics, and MM/PBSA estimates were compatible with this hypothesis but did not constitute experimental target validation. These data identify 4m as a starting point for DHPM-based antiproliferative agents and TOP2A as a hypothesis to be tested experimentally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, Al-Balqa Applied University, P.O. Box 206, Al-Salt 19117, Jordan.
- Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95125 Catania, Italy.
- Department of Chemistry, Faculty of Science, The Hashemite University, P.O. Box 330127, Zarqa 13133, Jordan.
- Department of Chemical Sciences, University of Catania, Viale A. Doria 6, 95125 Catania, Italy.
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale F. Stagno D'Alcontres 31, 98166 Messina, Italy.
ORCID-Profile: Rocco Buccheri, Anas J Rasras, Mohammad S Alzubi, Eyad A Younes, Placido Mineo, Francesco Cimino, Antonio Rescifina, Nicola Micale
Zitieren
APA
Sultan, H. D., Buccheri, R., Rasras, A. J., Alzubi, M. S., Younes, E. A., Mineo, P., Molonia, M. S., Cimino, F., Rescifina, A., & Micale, N. (2026). 3,4-Dihydropyrimidin-2(1H)-One Hybrids as Phenotypic Anti-Breast Cancer Agents: Synthesis, Colony-Formation Profiling and Computational Target Deconvolution. International Journal of Molecular Sciences, 27(21), 9618. https://doi.org/10.3390/ijms27219618
Vancouver
Sultan HD, Buccheri R, Rasras AJ, Alzubi MS, Younes EA, Mineo P, et al. 3,4-Dihydropyrimidin-2(1H)-One Hybrids as Phenotypic Anti-Breast Cancer Agents: Synthesis, Colony-Formation Profiling and Computational Target Deconvolution. International Journal of Molecular Sciences. 2026;27(21):9618. doi:10.3390/ijms27219618
BibTeX
@article{Sultan2026,
author = {Sultan, Hadeel D and Buccheri, Rocco and Rasras, Anas J and Alzubi, Mohammad S and Younes, Eyad A and Mineo, Placido and Molonia, Maria S and Cimino, Francesco and Rescifina, Antonio and Micale, Nicola},
title = {3,4-Dihydropyrimidin-2(1H)-One Hybrids as Phenotypic Anti-Breast Cancer Agents: Synthesis, Colony-Formation Profiling and Computational Target Deconvolution},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9618},
doi = {10.3390/ijms27219618}
}
EUVIMED